trial · primary record
Cadisegliatin 800 mg QD
Diabetes Mellitus, Type 1
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 150 |
| Primary completion | 2027-05 |
| Primary endpoint | Change in incidence of Level 2 or Level 3 hypoglycemia |
| Registry ID | NCT06334133 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:31.160Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06334133
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.